A robotic approach combined distal splenopancreatectomy and left nephrectomy in a complex case with renal infiltration from pancreatic adenocarcinoma. The procedure achieved negative margins and involved a multidisciplinary team to minimize conversion risk and enhance oncological outcomes. The patient was discharged on postoperative day 6, indicating a favorable recovery. Pathology revealed T4 cancer with two […]
Category: HPB & Spleen
Multivisceral Resection for Pancreatic Cancer: Comparable Outcomes
Multivisceral resection (MVR) for pancreatic ductal adenocarcinoma shows similar short-term outcomes to standard resection, but poorer long-term survival rates among selected patients. 2-year overall survival rate for MVR is 33.3% vs. 49.9% for standard resection (p=0.006). 2-year disease-free survival rate is 11.3% for MVR vs. 25.9% for standard resection (p=0.018). Surgeons should consider MVR for […]
Fragmented Care Impacts Pancreatic Cancer Outcomes
Fragmented care for pancreatic cancer patients at high-volume centers leads to delays in chemotherapy but not worse surgical outcomes. One-third of patients (n = 124) received fragmented care, often living farther from the center. Delayed chemotherapy initiation occurred in 17.6% of fragmented care patients compared to 5.6% of those receiving care solely at the center. […]
No Long-Term Outcome Difference in Gallbladder Cancer Resection
Surgeons can expect similar long-term outcomes when choosing between segment 4b/5 and wedge resection for gallbladder adenocarcinoma. 163 patients underwent randomized surgeries; segment 4b/5 took longer (318 min vs. 287 min) and had higher blood loss (265 ml vs. 223 ml). No differences in morbidity, mortality, or R0 resection rates were observed. At 27 months […]
New Biliary Drainage Technique for Altered Anatomy Shows Promise
A novel endoscopic approach improves biliary drainage outcomes for patients with altered anatomy. Technical success rate: 87.3%, clinical success: 93.8%. Adverse event rate: 20%, with 30.6% persistent fistula rate within 3 months. Consider this technique for patients with complex anatomy, especially when multiple biliary interventions are needed. Most common indication: benign strictures (58.2%). Multicenter Study […]
Improved Liver Retraction in Robotic Hepatectomy
A new technique for liver retraction during robotic surgery minimizes trauma and enhances surgical precision. Implemented in 26 robotic hepatectomies, the Clip-Pulley Maneuver (CPM) proved to be complication-free. No major events (Clavien-Dindo grade III or higher) were reported, and the diaphragm remained intact in all cases. This method allows real-time adjustments for optimal retraction without […]
Impact of Enhanced Recovery on Liver Surgery Outcomes
High compliance with enhanced recovery programs does not significantly improve survival after liver surgery. Among 1,860 patients, only 24.4% achieved high compliance. Twelve-month overall survival rates were similar: 96% for high compliance vs. 92% for low compliance (p = 0.11). Long-term mortality risks included metastatic disease and prolonged operative times. Only patients with colorectal liver […]
Robotic Taj Mahal Hepatectomy: A Game Changer for Type IV Cholangiocarcinoma
This study shows that robotic-modified Taj Mahal hepatectomy is a safe alternative for selected patients with type IV hilar cholangiocarcinoma, minimizing morbidity. Operative time was 560 minutes with only 300 ml blood loss. The postoperative course was smooth, with discharge on day 8 and no complications. This technique allows for a parenchyma-preserving approach, with one […]
Adjuvant Chemo Improves Survival in Gallbladder Cancer Post-Resection
In gallbladder cancer patients, adjuvant chemotherapy after curative resection significantly enhances survival and reduces recurrence risk. The 3-year overall survival rate was higher for chemotherapy patients at 73% versus 43% for those under observation. Progression-free survival also showed favorable outcomes for the chemotherapy group. Consider this data for selecting treatment strategies post-resection, as chemotherapy markedly […]
Predicting Malignancy in Pancreatic Mucinous Cystic Neoplasms
Surgeons can now identify high-grade dysplasia in pancreatic mucinous cystic neoplasms using an effective risk prediction model. In a study of 198 patients, 16% had high-grade dysplasia, with 7% showing invasive carcinoma. Key risk factors include older age (median 52.5 years), symptomatic presentation (72%), cyst size (average 85 mm), and mural nodules (56%). Utilize the […]
